Novo Nordisk launches once-weekly basal insulin Awiqli nationwide
Go back to Novo Nordisk launches once-weekly basal insulin Awiqli nationwide| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 45.34 -1.26 (2.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.60 | 52 Week High | $59.00 | |||
| Open | $45.58 | 52 Week Low | $32.80 | |||
| Day High | $45.91 | P/E | N/A | |||
| Day Low | $45.27 | EPS | $0.00 | |||
| Volume | 5,552,490 | |||||
